Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Bonate

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|April 23, 2021
Correction to: QTc interval analysis-an ever-evolving endeavorPeter L Bonate
Journal of Pharmacokinetics and Pharmacodynamics|October 10, 2020
The application of extreme value theory to pharmacometricsPeter L Bonate
Journal of Pharmacokinetics and Pharmacodynamics|February 16, 2024
Thoughts on plagiarism and the case against Claudine GayPeter L Bonate
Journal of Pharmacokinetics and Pharmacodynamics|May 4, 2013
Editorial to the themed issue on translational modeling in neurosciencePeter L Bonate
Pharmaceutical Statistics|April 23, 2013
Effect of assay measurement error on parameter estimation in concentration-QTc interval modelingPeter L Bonate
Journal of Pharmacokinetics and Pharmacodynamics|April 20, 2017
Estimation of QT interval prolongation through model-averagingPeter L Bonate
Journal of Pharmacokinetics and Pharmacodynamics|April 7, 2021
QTc interval analysis-an ever-evolving endeavorPeter L Bonate
Journal of Pharmacokinetics and Pharmacodynamics|January 5, 2013
The effects of active metabolites on parameter estimation in linear mixed effect models of concentration-QT analysesPeter L Bonate
The AAPS Journal|April 23, 2013
Effect of censoring due to progressive disease on tumor size kinetic parameter estimatesPeter L Bonate, Ben Suttle
Cancer Chemotherapy and Pharmacology|May 30, 2013
Modeling tumor growth kinetics after treatment with pazopanib or placebo in patients with renal cell carcinomaPeter L Bonate, A Benjamin Suttle
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Journal of Pharmacokinetics and Pharmacodynamics|April 23, 2021
Correction to: QTc interval analysis-an ever-evolving endeavorPeter L Bonate
Journal of Pharmacokinetics and Pharmacodynamics|October 10, 2020
The application of extreme value theory to pharmacometricsPeter L Bonate
Journal of Pharmacokinetics and Pharmacodynamics|February 16, 2024
Thoughts on plagiarism and the case against Claudine GayPeter L Bonate
Journal of Pharmacokinetics and Pharmacodynamics|May 4, 2013
Editorial to the themed issue on translational modeling in neurosciencePeter L Bonate
Pharmaceutical Statistics|April 23, 2013
Effect of assay measurement error on parameter estimation in concentration-QTc interval modelingPeter L Bonate
Journal of Pharmacokinetics and Pharmacodynamics|April 20, 2017
Estimation of QT interval prolongation through model-averagingPeter L Bonate
Journal of Pharmacokinetics and Pharmacodynamics|April 7, 2021
QTc interval analysis-an ever-evolving endeavorPeter L Bonate
Journal of Pharmacokinetics and Pharmacodynamics|January 5, 2013
The effects of active metabolites on parameter estimation in linear mixed effect models of concentration-QT analysesPeter L Bonate
The AAPS Journal|April 23, 2013
Effect of censoring due to progressive disease on tumor size kinetic parameter estimatesPeter L Bonate, Ben Suttle
Cancer Chemotherapy and Pharmacology|May 30, 2013
Modeling tumor growth kinetics after treatment with pazopanib or placebo in patients with renal cell carcinomaPeter L Bonate, A Benjamin Suttle
Pageof 7